I. Stojkovski, K. Kochova, I. Slaveska Spirevska, and E. Janevik-Ivanovska, “SPIRONOLACTONE ORAL SUSPENSION (5 mg/mL): FORMULATION STRATEGIES AND PHYSICOCHEMICAL CHARACTERIZATION”, kij, vol. 75, no. 4, pp. 347–354, Mar. 2026.